Phase 2 study for people with Multiple Sclerosis

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Vidya Therapeutics Inc
Registry number NCT07085507
Started 1 August 2025 Today 16 October 2026 Estimated completion 30 October 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
CMAX Adelaide SA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 65 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 100

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

Parts 1 and 2

* Age 18-65

* Must be in good health with no significant medical history

* Willing and able to attend all study visits and comply with study requirements, including lumbar puncture for CSF collection

* Able and willing to provide written informed consent

Part 3

* Age 18-60

* Must be in good health with no significant medical history

* MS diagnosis prior to Day 1 in accordance with 2017 McDonald criteria.

* Willing and able to attend all study visits and comply with study requirements, including lumbar puncture for CSF collection

* Able and willing to provide written informed consent

Exclusion Criteria:

* Evidence of clinically significant condition or disease

* Any physical or psychological condition that prohibits study completion

* Known history of illicit drug use or drug abuse, harmful alcohol use (at the -Investigator's discretion), alcoholism, and/or smoking or nicotine-containing product use within 7 days prior to the first dose of study agent

* History of severe allergic reactions or hypersensitivity

* Donation or loss of ≥ 1 unit of whole blood or plasma within 4 weeks prior to dosing

Dates on the record

Started 1 August 2025
Estimated completion 30 October 2026
Registry last updated 21 July 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 21 July 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.